Completed PHASE4 INTERVENTIONAL 3-arm NCT01047202

Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants

A Blinded, Randomized and Controlled Clinical Trial With Influenza A/H1N1 Split-virion Vaccine in 6 to 35 Months Infants

Sponsor: Sinovac Biotech Co., Ltd

Conditions Influenza

Interventions Pandemic influenza A/H1N1 vaccine Seasonal trivalent vaccine

Updated 5 times since 2017 Last updated: Mar 13, 2013 Started: Dec 31, 2009 Primary completion: Mar 31, 2010 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Sinovac Biotech Co., Ltd and has accumulated 5 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sinovac Biotech Co., Ltd

Data source: Sinovac Biotech Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guilin, China